Atrial Fibrillation, Anticoagulation, and Major Bleeding Episodes in Geriatric Patients at the Risk of Falling
Authors:
- Lennaert ZwartLZLennaert Zwart
- Tjeerd GermansTGTjeerd Germans
- Suat SimsekSSSuat Simsek
- Jaap RuiterJRJaap Ruiter
- René JansenRJRené Jansen
Open Access
- 26 August 2019
- journal article
- Published by LIDSEN Publishing Inc in OBM Geriatrics
- Vol. 03 (03) , 1-17
Abstract
Background: Geriatric patients are at risk of atrial fibrillation (AF) and stroke, and the risk of oral anticoagulation (OAC) related bleeding is also presumed to be higher. Detailed knowledge about the prevalence of AF and bleeding pattern in this population is scarce. This study sought to assess the prevalence of AF, use of OAC, and the rate of major bleeding in geriatric patients who are prone to frequent falls. We expect to find a higher prevalence of AF among geriatric patients compared to elderly people of comparable age. Methods: This was an observational cohort study conducted at the Fall and Syncope Clinic. Inclusion criteria: age >65 years, availability of both electrocardiogram (ECG) and Holter registration. The use and reasons to withhold OAC and the rate of major bleeding were retrieved from the medical files. Results: A total of 428 patients with the mean age of 79.8 years were analyzed. The mean number of morbidities was 11 ±5. AF was known in 98 (23%) patients, first diagnosed in 10 (2%). Among them, AF was paroxysmal in 45 (45%) patients, and 50% of them were first diagnosed cases. Of patients with AF, 84% were using OAC. The rate of major bleeding episodes was 1.1 per 100 treatment years. Major bleeding episodes were not different between the patients using antiplatelet agents (APA), OAC, or no antithrombotic medication. Conclusions: In this geriatric population, 23% of patients had AF and almost half were paroxysmal. Compared to previous studies, the use of OAC has substantially increased to 84% and no differences were found in the rate of major bleeding episodes between those using APA, OAC, or no antithrombotic medication.Keywords
This publication has 25 references indexed in Scilit:
- Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillationAmerican Heart Journal, 2019
- Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial FibrillationDrugs & Aging, 2018
- Management of Gait Changes and Fall Risk in MCI and DementiaCurrent Treatment Options in Neurology, 2017
- The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF StudyCanadian Journal of Cardiology, 2016
- Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)American Heart Journal, 2015
- Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation ProjectThe American Journal of Medicine, 2014
- Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAmerican Heart Journal, 2014
- Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation TherapyThe American Journal of Medicine, 2012
- Paroxysmal Atrial FibrillationArchives of internal medicine (1960), 1996
- Fall risk index for elderly patients based on number of chronic disabilitiesThe American Journal of Medicine, 1986